{
    "clinical_study": {
        "@rank": "137809", 
        "acronym": "MA/GH", 
        "arm_group": {
            "arm_group_label": "Amniotic membrane in large wounds", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to analyze the security application of the amniotic membrane in\n      extensive wounds in the granulation phase."
        }, 
        "brief_title": "Use of the Amniotic Membrane in Large Wound Epithelialization", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Wounds", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Acute wounds in granulation phase with a minimum area of \u200b\u200b100 cm2.\n\n          -  Patients 18 or more years.\n\n          -  Patients offering sufficient guarantees of adherence to protocol.\n\n          -  Sign the written informed consent.\n\n          -  Meet all inclusion criteria.\n\n        Exclusion Criteria:\n\n          -  Patients with symptomatic chronic arterial insufficiency.\n\n          -  Patients who are pregnant\n\n          -  Patients in active lactation\n\n          -  Patients physically fertile, defined as all women physiologically capable of becoming\n             pregnant, including women whose career, lifestyle or sexual orientation precludes\n             intercourse with a man and women whose partners have been sterilized by vasectomy or\n             other methods, UNLESS they are using reliable contraception. This method of\n             contraception can be:\n\n               -  Complete abstinence from sexual intercourse\n\n               -  Surgical sterilization (tubal ligation)\n\n               -  Surgical sterilization of the partner (vasectomy)\n\n               -  Implanted or injectable hormonal contraceptives, oral *\n\n               -  Because hormonal contraceptives have a risk of thrombosis, should consider other\n                  methods of birth control.\n\n        These reliable contraception must be maintained during their participation in the study.\n\n          -  Patients with heart, kidney, liver, systemic immune may influence the survival of the\n             patient during the test.\n\n          -  Participation in other clinical trials.\n\n          -  Inability to understand informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824381", 
            "org_study_id": "MA/GH", 
            "secondary_id": "2011-004395-11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Amniotic membrane in large wounds", 
                "description": "After the process of obtaining the amniotic membrane, it must be processed, frozen and thawed.\nThe wound is washed with saline and, if necessary it will be debrided. We will take microbiological control cultures. Then apply the amniotic membrane fragments sufficient to cover the wound by contacting the basal membrane of the amniotic membrane with granulation tissue.\nWe will place a new membrane weekly to a maximum of 6 times.", 
                "intervention_name": "Place amniotic membrane in large wounds", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Amniotic membrane in large wounds", 
                "intervention_name": "Obtaining and Cryopreservation of amniotic membrane", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Amniotic membrane in large wounds", 
                "intervention_name": "amniotic membrane", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "extensive wounds", 
            "amniotic membrane", 
            "healing", 
            "patients", 
            "phase granulation"
        ], 
        "lastchanged_date": "April 11, 2013", 
        "link": [
            {
                "description": "Official web of Spanish Stem Cell Network", 
                "url": "http://www.red-tercel.com"
            }, 
            {
                "description": "Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias Regi\u00f3n de Murcia", 
                "url": "http://www.ffis.es"
            }, 
            {
                "description": "Official web of Health Service of Murcia Region.", 
                "url": "http://www.murciasalud.es"
            }
        ], 
        "location": {
            "contact": {
                "email": "ffis-investigacion-sms@listas.carm.es", 
                "last_name": "Javier Judez, MD", 
                "phone": "+34968359777"
            }, 
            "facility": {
                "address": {
                    "city": "El Palmar", 
                    "country": "Spain", 
                    "state": "Murcia", 
                    "zip": "30120"
                }, 
                "name": "Clinical Universitary Hospital Virgen de la Arrixaca"
            }, 
            "investigator": [
                {
                    "last_name": "Gregorio Castellanos Escrig, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Antonio Pi\u00f1ero Madrona, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jos\u00e9 M Moraleda Jim\u00e9nez, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Miguel Blanquer Blanquer, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Andres Sanchez Salinas, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ana M Garc\u00eda Hern\u00e1ndez, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Joaqu\u00edn A G\u00f3mez Espuch, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Francisca Iniesta Mart\u00ednez, Graduate", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Francisco J Nicol\u00e1s Villaescusa, Md", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Enrique Mart\u00ednez Barba, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Manuel Muro Amador, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Genoveva Yag\u00fce Guirao, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fernando Santoyo Santonja, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of the Amniotic Membrane in Large Wound Epithelialization. Phase I Clinical Trial.", 
        "overall_contact": {
            "email": "gcastellanos@ono.com", 
            "last_name": "Gregorio Castellanos-Escrig, MD", 
            "phone": "+34968369532"
        }, 
        "overall_contact_backup": {
            "email": "ffis-investigacion-sms@listas.carm.es", 
            "last_name": "Javier Judez-Gutierrez, MD", 
            "phone": "+34968359777"
        }, 
        "overall_official": {
            "affiliation": "Clinical Universitary Hospital Virgen de la Arrixaca", 
            "last_name": "Gregorio Castellanos-Escrig, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Ministry of Health", 
                "Spain: Spanish Agency of Medicines"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "No serious adverse events possibly, probably or definitely related with the procedure.\nNo appearance of clinical inflammatory changes.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "Last revision at 3 years after surgery."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824381"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To assess the effects of the application of the amniotic membrane on reepithelialization of wounds by measuring the wound area.", 
                "measure": "Measurement of the wound area", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "description": "To assess the effects of the application of amniotic membrane in the symptomatology of patients through the development of local pain measured with a visual analog scale.", 
                "measure": "Evolution of local pain measured with a visual analog scale", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "To study the changes in the signaling pathways of TGFb in patients epithelium induced amniotic membrane.", 
                "measure": "Changes in the signaling pathways of TGFb.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Red de Terapia Celular", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias de la Regi\u00f3n de Murcia", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Facultad de Medicina. Universidad de Murcia.", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hospital Universitario Virgen de la Arrixaca", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "MurciaSalud", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Consejer\u00eda de Sanidad de la Comunidad Aut\u00f3noma de la Regi\u00f3n de Murcia", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Red de Terapia Celular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}